Sichuan Kelun Pharmaceutical Co., Ltd.

SZSE:002422 Stok Raporu

Piyasa değeri: CN¥52.4b

Sichuan Kelun Pharmaceutical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Sichuan Kelun Pharmaceutical yıllık ortalama 30.9% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 9% annual. Gelirler growing yılda ortalama 6.8% oranında artmaktadır. Sichuan Kelun Pharmaceutical'in özkaynak karlılığı 13.1% ve net marjı 13.2%'dir.

Anahtar bilgiler

30.9%

Kazanç büyüme oranı

29.7%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi10.9%
Gelir büyüme oranı6.8%
Özkaynak getirisi13.1%
Net Marj13.2%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Sichuan Kelun Pharmaceutical's (SZSE:002422) Earnings Are Weaker Than They Seem

May 02
Sichuan Kelun Pharmaceutical's (SZSE:002422) Earnings Are Weaker Than They Seem

Recent updates

Sichuan Kelun Pharmaceutical (SZSE:002422) Has A Rock Solid Balance Sheet

Oct 28
Sichuan Kelun Pharmaceutical (SZSE:002422) Has A Rock Solid Balance Sheet

Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Low P/E No Reason For Excitement

Sep 22
Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Low P/E No Reason For Excitement

Should You Be Adding Sichuan Kelun Pharmaceutical (SZSE:002422) To Your Watchlist Today?

Aug 16
Should You Be Adding Sichuan Kelun Pharmaceutical (SZSE:002422) To Your Watchlist Today?

Is Sichuan Kelun Pharmaceutical (SZSE:002422) Using Too Much Debt?

Jul 12
Is Sichuan Kelun Pharmaceutical (SZSE:002422) Using Too Much Debt?

Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Prospects Need A Boost To Lift Shares

Jun 11
Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Prospects Need A Boost To Lift Shares

An Intrinsic Calculation For Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Suggests It's 45% Undervalued

May 21
An Intrinsic Calculation For Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Suggests It's 45% Undervalued

Sichuan Kelun Pharmaceutical's (SZSE:002422) Earnings Are Weaker Than They Seem

May 02
Sichuan Kelun Pharmaceutical's (SZSE:002422) Earnings Are Weaker Than They Seem

If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity

Mar 19
If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity

Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement

Mar 04
Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement

These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely

Feb 27
These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely

Gelir ve Gider Dağılımı

Sichuan Kelun Pharmaceutical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SZSE:002422 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2422,5002,9645,2661,862
30 Jun 2422,4822,8525,4651,946
31 Mar 2422,0352,6685,6501,955
31 Dec 2321,4542,4565,6281,944
30 Sep 2320,8412,2635,4472,256
30 Jun 2320,7122,2415,5402,037
31 Mar 2320,1942,2285,6251,870
01 Jan 2319,0381,7055,7071,795
30 Sep 2218,5311,6605,5481,752
30 Jun 2218,1701,4785,7201,805
31 Mar 2217,6081,2185,8741,735
01 Jan 2217,2771,1035,9131,737
30 Sep 2117,4871,1765,8681,717
30 Jun 2117,4651,1196,0581,608
31 Mar 2117,0789835,9531,620
31 Dec 2016,4648295,6511,527
30 Sep 2016,3425256,4141,503
30 Jun 2015,9454126,5251,443
31 Mar 2016,8866247,1571,358
31 Dec 1917,6369387,5761,286
30 Sep 1917,0781,1047,4931,070
30 Jun 1917,4821,1677,5881,048
31 Mar 1916,7081,1657,020968
31 Dec 1816,3521,2136,839909
30 Sep 1815,7571,3846,587866
30 Jun 1814,2851,2655,3221,102
31 Mar 1812,9339384,677906
31 Dec 1711,4357483,854712
30 Sep 1710,2234343,005467
30 Jun 179,4124552,9610
31 Mar 178,9965692,6780
31 Dec 168,5665852,5010
30 Sep 168,1986322,2640
30 Jun 168,0246222,2350
31 Mar 167,8756482,1140
31 Dec 157,7636452,0560
30 Sep 157,8567271,8660
30 Jun 157,8928741,7800
31 Mar 157,9769801,7880
31 Dec 148,0231,0021,7710
30 Sep 147,8881,0571,7540
30 Jun 147,6171,0821,6590
31 Mar 147,3101,1011,5880
31 Dec 136,8311,0801,4990

Kaliteli Kazançlar: 002422 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: 002422 'nin mevcut net kar marjları (13.2%) geçen yılın (10.9%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 002422 şirketinin kazançları son 5 yılda yılda 30.9% oranında önemli ölçüde arttı.

Büyüme Hızlandırma: 002422 'un son bir yıldaki kazanç büyümesi ( 31% ) 5 yıllık ortalamasını (yıllık 30.9% ) aşıyor.

Kazançlar vs. Sektör: 002422 geçen yılki kazanç büyümesi ( 31% ) Pharmaceuticals sektörünün -1.2% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: 002422 'nin Özsermaye Getirisi ( 13.1% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin